Curaleaf Holdings, Inc.
Curaleaf is a cannabis company with operations in U.S. states that permit medical or adult-use cannabis, and international businesses focused on cannabis products. In the U.S., it holds licenses for cultivation, manufacturing, processing, distribution and sales in Arizona, Connecticut, Florida, Illinois, Maine, Maryland, Massachusetts, Missouri, Nevada, New Jersey, New York, North Dakota, Ohio, Pennsylvania and Utah. It also operates a medical cannabis wholesale business in Poland and has international cultivation, processing and distribution activities, including in Canada, Portugal, Germany and the U.K. Curaleaf makes money through cannabis sales and distribution. Its activities include medical and adult-use retail, wholesale distribution of medical cannabis and cannabinoid products, and production and processing of cannabis flower. Its brands include Curaleaf Poland, which specializes in acquiring, registering and distributing medical cannabis and products containing THC and other cannabinoids. Curaleaf is headquartered in Stamford, Connecticut.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $CURLF in the last 30 days.
See all $CURLF insider activity →Organigram to acquire Aurora for C$7.80 per share, a 93% premium over Aurora's unaffected price. The deal, supported by both boards, values Aurora at approximately C$1.33B. Aurora shareholders can choose cash, shares, or a mix. The combined company aims to enhance scale, supply chain, and global footprint. Organigram's significant shareholder, BAT, will participate in financing.
Curaleaf acquired a stake in Boone Town Provisions, adding a fourth dispensary in New Jersey and 191 nationwide. The company expects the acquisition to be immediately beneficial to its New Jersey operations and was made at an attractive valuation, according to Curaleaf.
Curaleaf Holdings, Inc. (CURLF) filed an SEC Form 8-K — Regulation FD Disclosure. Curaleaf Holdings, Inc. Investor Relations Curaleaf Acquires Equity Interest in Boone Town Provisions, Expanding New Jersey Footprint to Four Dispensaries STAMFORD, Conn., Nov. 2, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (the "Company"), a leading i
Over the past 7 days, AlphAI's AI scored 7 news stories mentioning CURLF (Curaleaf Holdings, Inc.). Coverage has skewed bullish: 6 bullish, 1 neutral, and 0 bearish.
Recent CURLF coverage spans mergers & acquisitions, regulation and corporate actions.
Organigram to acquire Aurora for C$7.80 per share, a 93% premium over Aurora's unaffected price. The deal, supported by both boards, values Aurora at approximately C$1.33B. Aurora shareholders can choose cash, shares, or a mix. The combined company aims to enhance scale, supply chain, and global footprint. Organigram's significant shareholder, BAT, will participate in financing.
The acquisition adds a new location in a high-demand area, expected to be immediately accretive to Curaleaf's New Jersey business.
The acquisition adds a high‑performing location, likely boosting Curaleaf's New Jersey revenue and supporting its share price.
The NJ Cannabis Regulatory Commission (NJCRC) extended Curaleaf's 12 licenses until December 31, 2026, despite an ongoing labor lawsuit. The commission denied Curaleaf's request to use additional pesticides. Commissioner Krista Nash criticized Curaleaf for non-compliance with state laws. The NJCRC also approved several cannabis license ownership changes, a drive-through dispensary, and satellite dispensary locations.
Cannara Biotech (LOVE) reports 21 quarters of positive adjusted EBITDA with a 27% margin. The company plans a CAD 30 million expansion by 2027, targeting EU GMP certification by January 2028, according to its growth strategy presented at the Planet MicroCap Showcase.
AlphAI scores every news story that mentions CURLF with an AI model for sentiment and relevance, and aggregates insider trades from Curaleaf Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Organigram to acquire Aurora for C$7.80 per share, a 93% premium over Aurora's unaffected price. The deal, supported by both boards, values Aurora at approximately C$1.33B. Aurora shareholders can choose cash, shares, or a mix. The combined company aims to enhance scale, supply chain, and global footprint. Organigram's significant shareholder, BAT, will participate in financing.
6 min readCuraleaf acquired a stake in Boone Town Provisions, adding a fourth dispensary in New Jersey and 191 nationwide. The company expects the acquisition to be immediately beneficial to its New Jersey operations and was made at an attractive valuation, according to Curaleaf.
1 min readCuraleaf Holdings, Inc. (CURLF) filed an SEC Form 8-K — Regulation FD Disclosure. Curaleaf Holdings, Inc. Investor Relations Curaleaf Acquires Equity Interest in Boone Town Provisions, Expanding New Jersey Footprint to Four Dispensaries STAMFORD, Conn., Nov. 2, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (the "Company"), a leading i
1 min readThe NJ Cannabis Regulatory Commission (NJCRC) extended Curaleaf's 12 licenses until December 31, 2026, despite an ongoing labor lawsuit. The commission denied Curaleaf's request to use additional pesticides. Commissioner Krista Nash criticized Curaleaf for non-compliance with state laws. The NJCRC also approved several cannabis license ownership changes, a drive-through dispensary, and satellite dispensary locations.
7 min readCannara Biotech (LOVE) reports 21 quarters of positive adjusted EBITDA with a 27% margin. The company plans a CAD 30 million expansion by 2027, targeting EU GMP certification by January 2028, according to its growth strategy presented at the Planet MicroCap Showcase.
1 min readCuraleaf Holdings, Inc. (CURLF) filed an SEC Form 8-K — Other Events. Curaleaf Holdings, Inc. Investor Relations Curaleaf Responds to Alberta Securities Commission Decision STAMFORD, Conn., Oct. 27, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf"), a leading international provider of consumer and medical cannabis
2 min readCuraleaf (CURA, CURLF) responded to the Alberta Securities Commission's ruling, reiterating its enhanced offer for Aurora Cannabis (ACB), which it claims represents an 86% premium. Curaleaf argues that a merger would create a global cannabis leader with operations in 17 countries and over $1.5 billion in past-year revenue. Aurora has been criticized for using an ATM program to issue shares at lower prices before Curaleaf's bid.
2 min readThe DEA opposed delays in marijuana rescheduling proceedings, calling opponents' requests a 'fishing expedition.' Curaleaf (CURLF), a cannabis company, faces regulatory uncertainty. Its P/S ratio is 1.69, below historical levels, and it has a GF Score of 73/100, with weak financial strength and profitability.
2 min readCuraleaf (CURA) claims Aurora rejected its enhanced hostile bid, citing an 86% premium to Aurora’s 30-day VWAP. Curaleaf states its bid uses standard conditions and remains ready to engage. Aurora has not granted diligence.
2 min readNORML has urged a federal appeals court to reconsider a ruling that overturned a $31.8 million verdict against Curaleaf subsidiaries for breaching a marijuana supply contract. The case, Hello Farms v. GR Vending, involves a dispute over a 2020 agreement where Curaleaf stopped accepting deliveries as prices declined.
2 min read
